BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15389640)

  • 21. Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells.
    Ribeiro AS; Albergaria A; Sousa B; Correia AL; Bracke M; Seruca R; Schmitt FC; Paredes J
    Oncogene; 2010 Jan; 29(3):392-402. PubMed ID: 19901964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caveolin-1 is an important factor for the metastasis and proliferation of human small cell lung cancer NCI-H446 cell.
    Yeh D; Chen C; Sun MZ; Shao S; Hao L; Song Y; Gong L; Hu J; Wang Q
    Anat Rec (Hoboken); 2009 Oct; 292(10):1584-92. PubMed ID: 19718715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Novel mutation-specific monoclonal E-cadherin antibodies make possible allele differentiation at the protein level in tumors].
    Becker I; Becker KF; Kremmer E; Eulitz M; Handschuh G; Höfler H
    Verh Dtsch Ges Pathol; 1999; 83():233-9. PubMed ID: 10714216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
    Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
    J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
    Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q
    Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.
    Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H
    Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo.
    Schwartz B; Melnikova VO; Tellez C; Mourad-Zeidan A; Blehm K; Zhao YJ; McCarty M; Adam L; Bar-Eli M
    Oncogene; 2007 Jun; 26(28):4049-58. PubMed ID: 17224907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14).
    Covington MD; Burghardt RC; Parrish AR
    Am J Physiol Renal Physiol; 2006 Jan; 290(1):F43-51. PubMed ID: 16077081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polysialylated NCAM represses E-cadherin-mediated cell-cell adhesion in pancreatic tumor cells.
    Schreiber SC; Giehl K; Kastilan C; Hasel C; Mühlenhoff M; Adler G; Wedlich D; Menke A
    Gastroenterology; 2008 May; 134(5):1555-66. PubMed ID: 18384787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in classical cadherins associated with progression in ulcerative and Crohn's colitis.
    Jankowski JA; Bedford FK; Boulton RA; Cruickshank N; Hall C; Elder J; Allan R; Forbes A; Kim YS; Wright NA; Sanders DS
    Lab Invest; 1998 Sep; 78(9):1155-67. PubMed ID: 9759659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells.
    Mateus AR; Seruca R; Machado JC; Keller G; Oliveira MJ; Suriano G; Luber B
    Hum Mol Genet; 2007 Jul; 16(13):1639-47. PubMed ID: 17510211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
    Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation.
    Hulit J; Suyama K; Chung S; Keren R; Agiostratidou G; Shan W; Dong X; Williams TM; Lisanti MP; Knudsen K; Hazan RB
    Cancer Res; 2007 Apr; 67(7):3106-16. PubMed ID: 17409417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion.
    Klucky B; Mueller R; Vogt I; Teurich S; Hartenstein B; Breuhahn K; Flechtenmacher C; Angel P; Hess J
    Cancer Res; 2007 Sep; 67(17):8198-206. PubMed ID: 17804733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation.
    Dwivedi A; Slater SC; George SJ
    Cardiovasc Res; 2009 Jan; 81(1):178-86. PubMed ID: 18852254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional allelic loss detected at the protein level in archival human tumours using allele-specific E-cadherin monoclonal antibodies.
    Becker KF; Kremmer E; Eulitz M; Schulz S; Mages J; Handschuh G; Wheelock MJ; Cleton-Jansen AM; Höfler H; Becker I
    J Pathol; 2002 Aug; 197(5):567-74. PubMed ID: 12210074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The E-cadherin-repressed hNanos1 gene induces tumor cell invasion by upregulating MT1-MMP expression.
    Bonnomet A; Polette M; Strumane K; Gilles C; Dalstein V; Kileztky C; Berx G; van Roy F; Birembaut P; Nawrocki-Raby B
    Oncogene; 2008 Jun; 27(26):3692-9. PubMed ID: 18223680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells.
    Kajiyama H; Kikkawa F; Khin E; Shibata K; Ino K; Mizutani S
    Cancer Res; 2003 May; 63(9):2278-83. PubMed ID: 12727850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma.
    Kuniyasu H; Ellis LM; Evans DB; Abbruzzese JL; Fenoglio CJ; Bucana CD; Cleary KR; Tahara E; Fidler IJ
    Clin Cancer Res; 1999 Jan; 5(1):25-33. PubMed ID: 9918199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma.
    Zhao WB; Li Y; Liu X; Zhang LY; Wang X
    Int J Mol Med; 2008 Aug; 22(2):187-92. PubMed ID: 18636172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.